DOCSLIB.ORG

Sustaining the Response: Pandemics, Border Controls and International Travel

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sustaining the Response: Pandemics, Border Controls and International Travel Transcript Sustaining the Response: Pandemics, Border Controls and International Travel Professor David Heymann CBE Distinguished Fellow, Global Health Programme, Chatham House, Executive Director, Communicable Diseases Cluster, World Health Organization (1998-2003) Professor Kelley Lee Professor, Canada Research Chair Tier I, Simon Fraser University Alexandre de Juniac Director-General and CEO, International Air Transport Association (IATA) Chair: Emma Ross Senior Consulting Fellow, Global Health Programme, Chatham House Event date: 26 February 2021 The views expressed in this document are the sole responsibility of the speaker(s) and participants, and do not necessarily reflect the view of Chatham House, its staff, associates or Council. Chatham House is independent and owes no allegiance to any government or to any political body. It does not take institutional positions on policy issues. This document is issued on the understanding that if any extract is used, the author(s)/speaker(s) and Chatham House should be credited, preferably with the date of the publication or details of the event. Where this document refers to or reports statements made by speakers at an event, every effort has been made to provide a fair representation of their views and opinions. The published text of speeches and presentations may differ from delivery. © The Royal Institute of International Affairs, 2021. 10 St James’s Square, London SW1Y 4LE T +44 (0)20 7957 5700 F +44 (0)20 7957 5710 www.chathamhouse.org Patron: Her Majesty The Queen Chair: Jim O’Neill Director: Dr Robin Niblett Charity Registration Number: 208223 2 Sustaining the Response: Pandemics, Border Controls and International Travel Emma Ross Good afternoon and thanks for joining us again for the Chatham House COVID-19 webinar series with our distinguished Fellow, Professor David Heymann. Today we’re going to be talking about what’s going on across the world with border controls and travel restrictions and with getting everyone back to international travel and how the new variants and the vaccines are likely to influence how we travel, for the foreseeable future. With us to discuss this are Kelley Lee and Alexandre de Juniac. Kelley is an expert in international relations and global health governance at Simon Fraser University in Canada. A big focus of her research at the moment is her leadership of the Pandemics and Borders Project, which is tracking the use of travel restrictions and other cross-border measures during the pandemic. Alexandre is the Director General and CEO of IATA, which is the International Air Transport Association, the body that represents the global aviation industry. He has almost three decades of experience in both the private and public sectors, including senior positions in the airline and aerospace industry and the French Government. And of course, IATA is in the thick of what’s going on at the global level, in terms of trying to work out how to get everyone flying again in the COVID era and beyond, but there’s still a lot to be done in the COVID era. So, I think also on hand with Alexandre is David Powell, IATA’s medical advisor, in case there are any more technical questions that he might need to respond to, but I’m not sure that that’s still the case, but anyway, welcome to you all, and thank you for joining us. Before we dive in, the usual housekeeping and the event’s on the record, and to ask a question, please write them at any time in the ‘Q&A’ function on Zoom. Upvoted questions are more likely to be selected, so, please use that if you like a question. So, we will start now. A lot of hope is being pinned on vaccination as the way through this, as we know, and of course, the emergence of the new variants has shown that it may not be that simple, as well as the different perceptions of the different vaccines. Similar issues with the prospect of mutual recognition of the various test results. As if that wasn’t complicated enough, you’ve also got fake test result documents being bought on the internet, the prospect of vaccination certification fraud, even fake vaccines. Anyway, it’s a bit of a nightmare, so there’s lots to sort out on this. I’m going to start, David, with you, if I may? The issue of border closures or border measures, travel restrictions, is a bit controversial, especially as it’s so economically damaging, but disease does spread through international travel, doesn’t it? I mean, before we get into the discussion of what’s been going on with border controls and travel restrictions, David, can you kick us off by outlining, purely from an infectious disease control point of view, what the evidence says about whether and how taking measures at points of entry affects the spread at any stage of an outbreak. I mean, what’s actually effective in this area? Professor David Heymann CBE Well, thanks, Emma, and thanks to our colleagues who have joined today. Clearly, borders are the focus of attention because they’re where passengers travel internationally. But history has shown that border controls are not a permanent solution to stopping the spread of infectious diseases internationally. In SARS it clearly showed that disease could spread in the incubation period, while people were infected yet show up in another country. And so, generally, infectious diseases, the most important way of dealing with diseases that come in from outside, is to have good disease detection and response networks around the country, to rapidly detect and respond. 3 Sustaining the Response: Pandemics, Border Controls and International Travel However, with this current pandemic there are many new tools that may make it even more possible to do some type of examination at borders, if countries decide to do that, in order to make sure that people are, at least at the time they cross the border, not showing that they have infection. And these include new diagnostic tests, which can rapidly, within 15 minutes, show if someone is positive, but not all positives will be picked up by this method. There’s also been attempts to try heat and temperature scanning. This shows if people are sick, but it, itself, has not been shown to stop disease from spreading across borders, because again, it can spread in people in who are not showing a fever symptom. Though, there are many new tools that are available. There are vaccines now coming online as well, and all of these will play a role, certainly in getting us back to safe travel, but we have to remember that vaccines need to have equitable distribution, that there are human rights issues about quarantining at border posts, and a whole series of things that need to be worked out, and that are being tried for the first time during this pandemic. So right now, we’re learning a lot that’s new. We’ve seen that borders do not stop disease from entering countries, but that possibly you can decrease the entry of disease and make travel safer by some of the new tools and new mechanisms that are being used during the COVID pandemic. Emma Ross Okay, thank you, David, that’s a great start. Kelley, I’m going to move to you, if I may. What do you think is notable about how the border controls issue has been playing out during the pandemic, and could it have been any different? Professor Kelley Lee Yes, well, thanks, first of all, for inviting me to join you all. It’s a really complicated area and more complicated than I ever imagined. So, we’re one year into the project, Pandemics and Borders Project, and what we’ve noticed most strikingly is the diversity of practices that have been going on across different countries. So, what we’ve done is, we’ve been analysing this large dataset of every country’s use of cross-border measures during COVID-19. And there’s a couple of key variations in how people or how governments have responded during the pandemic. Firstly, there’s very big differences in who is permitted to travel. There’s all sorts of conditions of – which really gives you eligibility to travel. It might be based on citizenship, residence, purpose of your travel, often we hear the term ‘essential travel’, it could be your occupation, for example, and of course, infection status. So, these permissions are sometimes based on some sort of risk analysis. It might be, you know, because you’re from a high-risk country, or it’s largely often because of political and economic factors. If you needed, for example, migrant workers to come and pick agricultural crops. So that’s a sort of economic factor. So, there’s wide, wide variation in how countries have dealt with who’s permitted to travel. You think about Australia putting a cap on the number of people that can arrive internationally and it has to be, you know, usually Australian citizens or residents. And then you think about the UK, which has more of a risk-based approach, with its red list of countries, and so, that’s the first thing. And the second variation really is about the conditions under which travel is permitted. So again, large variation, this involves health screening, testing, quarantine isolation and contact tracing. All of these measures that are used in different ways and different combinations, different points of a traveller’s journey, and also, with different levels of stringency. So, all of this, you know, creates a really complicated 4 Sustaining the Response: Pandemics, Border Controls and International Travel picture about who’s doing what and really about how we understand which is the most effective, which isn’t effective, which is not necessary and so on, and that’s what we’re trying to figure out in our project.
Load more

Recommended publications
  • Open PDF 502KB
    COR0251 Supplementary written evidence submitted by Kelley Lee, Julianne Piper and Benoit Gomis, Pandemics and Borders Project, Faculty of Health Sciences, Simon Fraser University, Canada (COR0251) WHAT ARE YOUR MAIN RECOMMENDATIONS FOR EFFECTIVE BORDER MANAGEMENT OVER THE NEXT 12 MONTHS? 1. The UK, and other countries with rising vaccination levels, are entering a challenging period in relation to border management. Increased vaccination means lower transmission and thus pressures to relax public health measures including increased travel domestically and abroad. At the same time, the volume of circulating virus globally, new variants continue to evolve, with those more transmissible and virulent, and/or vaccine-evasive VOC moving the goalposts on herd immunity. 2. Most disruptive would be if a partial-escape variant emerges, i.e., one able to infect a significant number of fully vaccinated people and cause severe disease. A recent study modelled different scenarios in Canada for vaccine coverage and efficacy. The most damaging, by far, was a partial-escape variant. COVID-19 cases, hospitalizations and deaths were predicted to be twice as high as the next most serious scenario.1 Even with 75% full vaccination of the total population (Canada’s present target for the end of the summer), a partial-escape variant could result in a fourth wave. Even at 90% full vaccination, the study showed a partial-escape variant would be disruptive. 3. Effective management of travel-related risks will thus be critical over next 12-18 months, particularly given slow progress on achieving global equity in access to vaccines. There are risks to the gains achieved from mass vaccination.
    [Show full text]
  • COVID-19: Make It the Last Pandemic
    COVID-19: Make it the Last Pandemic Disclaimer: The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Independent Panel for Pandemic Preparedness and Response concerning the legal status of any country, territory, city of area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Report Design: Michelle Hopgood, Toronto, Canada Icon Illustrator: Janet McLeod Wortel Maps: Taylor Blake COVID-19: Make it the Last Pandemic by The Independent Panel for Pandemic Preparedness & Response 2 of 86 Contents Preface 4 Abbreviations 6 1. Introduction 8 2. The devastating reality of the COVID-19 pandemic 10 3. The Panel’s call for immediate actions to stop the COVID-19 pandemic 12 4. What happened, what we’ve learned and what needs to change 15 4.1 Before the pandemic — the failure to take preparation seriously 15 4.2 A virus moving faster than the surveillance and alert system 21 4.2.1 The first reported cases 22 4.2.2 The declaration of a public health emergency of international concern 24 4.2.3 Two worlds at different speeds 26 4.3 Early responses lacked urgency and effectiveness 28 4.3.1 Successful countries were proactive, unsuccessful ones denied and delayed 31 4.3.2 The crisis in supplies 33 4.3.3 Lessons to be learnt from the early response 36 4.4 The failure to sustain the response in the face of the crisis 38 4.4.1 National health systems under enormous stress 38 4.4.2 Jobs at risk 38 4.4.3 Vaccine nationalism 41 5.
    [Show full text]
  • Theglobalforum Thewho and the COVID-19 Pandemic
    Global Governance 26 (2020) 523–533 brill.com/gg The Global Forum ∵ The WHO and the COVID-19 Pandemic Less Reform, More Innovation Kelley Lee Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada Julianne Piper Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada 1 Introduction Public displays of gratitude around the world, championing frontline health workers as heroes during the COVID-19 pandemic, have contrasted sharply with the criticisms directed toward the World Health Organization (WHO). As the “directing and coordinating body for international health work,” the UN specialized agency has arguably been at the front line of the front line, gathering essential epidemic intelligence, convening scientific research col- laborations, and compiling technical guidelines on diagnostics, clinical care, prevention, and mitigation strategies. While playing this unique role, including regular media briefings throughout the pandemic, WHO officials have fielded questions about its performance against the backdrop of relentless increases in coronavirus infections and deaths worldwide. The withdrawal of funding and membership by the US government,1 and resolution adopted by Member 1 Trump 2020. © koninklijke brill nv, leiden, 2020 | doi:10.1163/19426720-02604005Downloaded from Brill.com09/28/2021 08:52:41AM via free access 524 the global forum States at the 73rd World Health Assembly “to initiate … [an] impartial, inde- pendent and comprehensive evaluation … [of] the WHO-coordinated interna- tional health response to COVID-19,”2 reflects a concerning loss of confidence in the WHO at a time when the world needs it the most. So, how did we get here and what is the way forward? To answer these questions, it is important to distinguish between short-term political points scoring by the Donald Trump administration to explain a floun- dering national pandemic response during an election year, and long-standing challenges at the heart of global health governance.
    [Show full text]
  • The Covid-19 Pandemic, Geopolitics, and International Law
    journal of international humanitarian legal studies 11 (2020) 237-248 brill.com/ihls The covid-19 Pandemic, Geopolitics, and International Law David P Fidler Adjunct Senior Fellow, Council on Foreign Relations, USA [email protected] Abstract Balance-of-power politics have shaped how countries, especially the United States and China, have responded to the covid-19 pandemic. The manner in which geopolitics have influenced responses to this outbreak is unprecedented, and the impact has also been felt in the field of international law. This article surveys how geopolitical calcula- tions appeared in global health from the mid-nineteenth century through the end of the Cold War and why such calculations did not, during this period, fundamentally change international health cooperation or the international law used to address health issues. The astonishing changes in global health and international law on health that unfolded during the post-Cold War era happened in a context not characterized by geopolitical machinations. However, the covid-19 pandemic emerged after the bal- ance of power had returned to international relations, and rival great powers have turned this pandemic into a battleground in their competition for power and influence. Keywords balance of power – China – coronavirus – covid-19 – geopolitics – global health – International Health Regulations – international law – pandemic – United States – World Health Organization © koninklijke brill nv, leiden, 2020 | doi:10.1163/18781527-bja10010 <UN> 238 Fidler 1 Introduction A striking feature of the covid-19 pandemic is how balance-of-power politics have influenced responses to this outbreak.1 The rivalry between the United States and China has intensified because of the pandemic.
    [Show full text]
  • Human Rights in Global Health Governance
    THE SCHOLARLY JOURNAL FOR THE NEW HEALTH SECURITY PARADIGM PEER REVIEWED, OPEN ACCESS JOURNAL ISSN 1939-2389 GLOBAL HEALTH GOVERNANCE IS AN OPEN ACCESS, PEER-REVIEWED, ONLINE JOURNAL THAT PROVIDES A PLATFORM FOR ACADEMICS AND PRACTITIONERS TO EXPLORE GLOBAL HEALTH ISSUES AND THEIR IMPLICATIONS FOR GOVERNANCE AND SECURITY AT NATIONAL AND INTERNATIONAL LEVELS. THE JOURNAL PROVIDES INTERDISCIPLINARY ANALYSES AND A VIGOROUS EXCHANGE OF PERSPECTIVES THAT ARE ESSENTIAL TO THE UNDERSTANDING OF THE NATURE OF GLOBAL HEALTH CHALLENGES AND THE STRATEGIES AIMED AT THEIR SOLUTION. THE JOURNAL IS PARTICULARLY INTERESTED IN ADDRESSING THE POLITICAL, ECONOMIC, SOCIAL, MILITARY AND STRATEGIC ASPECTS OF GLOBAL HEALTH ISSUES. PUBLISHER THE SCHOOL OF DIPLOMACY AND INTERNATIONAL RELATIONS, SETON HALL UNIVERSITY EDITOR YANZHONG HUANG SPECIAL GUEST EDITORS BENJAMIN MASON MEIER & LAWRENCE O. GOSTIN MANAGING EDITOR COURTNEY PAGE-TAN ASSOCIATE EDITORS ELIZAVETA HUTTENLOCHER CHARITY HUNG JENNA KARP JESSICA S KIERNAN GABRIELLA MELTZER JENNY DODSON MISTRY CAITLIN REID CECILIA ZVOSEC GLOBAL HEALTH GOVERNANCE, VOLUME XII, NO. 1 (SPRING 2018) HTTP://WWW.GHGJ.ORG THE SCHOLARLY JOURNAL FOR THE NEW HEALTH SECURITY PARADIGM PEER REVIEWED, OPEN ACCESS JOURNAL ISSN 1939-2389 EDITORIAL BOARD OBIJIOFOR AGINAM KERMIT JONES UNITED NATIONS UNIVERSITY HYMAN, PHELPS AND MCNAMARA, P.C. MELY CABALLERO-ANTHONY ADAM KAMRADT-SCOTT NANYANG TECHNOLOGICAL UNIVERSITY CENTRE FOR INTERNATIONAL SECURITY STUDIES, UNIVERSITY OF SYDNEY JOSHUA BUSBY UNIVERSITY OF TEXAS TIM K. MACKEY UNIVERSITY OF CALIFORNIA SAN DIEGO, JEAN-PAUL CHRETIEN SCHOOL OF MEDICINE US NAVY, DEPARTMENT OF DEFENSE/ARMED FORCES HEALTH ROBERT MARTEN SURVEILLANCE CENTER LSHTM SARA DAVIES SUERIE MOON QUEENSLAND UNIVERSITY OF TECHNOLOGY HARVARD KENNEDY SCHOOL SARA GORMAN PETER NAVARIO JANSSEN GLOBAL PUBLIC HEALTH NEW YORK UNIVERSITY’S COLLEGE OF GLOBAL PUBLIC HEALTH KAREN A.
    [Show full text]
  • Framing Global Health
    This article was downloaded by: [86.153.174.247] On: 13 March 2013, At: 02:04 Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Global Public Health: An International Journal for Research, Policy and Practice Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/rgph20 Framing global health: The governance challenge Colin McInnes a , Adam Kamradt-Scott c , Kelley Lee b d , David Reubi b e , Anne Roemer-Mahler b , Simon Rushton a , Owain David Williams a & Marie Woodling a a Department of International Politics, Centre for Health and International Relations (CHAIR), Aberystwyth University, Aberystwyth, UK b Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK c Centre for International Security Studies (CIIS), University of Sydney, Sydney, Australia d Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada e School of Global Studies, University of Sussex, Brighton, UK Version of record first published: 31 Oct 2012. To cite this article: Colin McInnes , Adam Kamradt-Scott , Kelley Lee , David Reubi , Anne Roemer- Mahler , Simon Rushton , Owain David Williams & Marie Woodling (2012): Framing global health: The governance challenge, Global Public Health: An International Journal for Research, Policy and Practice, 7:sup2, S83-S94 To link to this article: http://dx.doi.org/10.1080/17441692.2012.733949 PLEASE SCROLL DOWN FOR ARTICLE Full terms and conditions of use: http://www.tandfonline.com/page/terms-and- conditions This article may be used for research, teaching, and private study purposes.
    [Show full text]
  • Building a Multisystemic Understanding Of
    Analysis Building a multisystemic understanding BMJ Glob Health: first published as 10.1136/bmjgh-2021-006794 on 22 July 2021. Downloaded from of societal resilience to the COVID-19 pandemic 1 1 2 3 Didier Wernli , Mia Clausin, Nino Antulov- Fantulin, John Berezowski, 4 5 6 7 Nikola Biller, Karl Blanchet , Lucas Böttcher, Claudine Burton- Jeangros, Gérard Escher,8 Antoine Flahault,9 Keiji Fukuda,10 Dirk Helbing,2 Philip D Jaffé,11 Peter Søgaard Jørgensen,12,13 Yuliya Kaspiarovich,1 Jaya Krishnakumar,14 15 16 1 1,17 Roderick John Lawrence, Kelley Lee , Anaïs Léger, Nicolas Levrat, 18 1 18 19,20 Romain Martischang, Chantal M Morel , Didier Pittet, Maxime Stauffer, Fabrizio Tediosi,21,22 Flore Vanackere,1 Jean- Dominique Vassalli,23,24 Gaélane Wolff,25 Oran Young26 To cite: Wernli D, Clausin M, ABSTRACT Summary box Antulov- Fantulin N, et al. The current global systemic crisis reveals how globalised Building a multisystemic societies are unprepared to face a pandemic. Beyond ► The COVID-19 pandemic has tested resilience in understanding of societal the dramatic loss of human life, the COVID-19 pandemic resilience to the COVID-19 health but also social, economic, environmental and has triggered widespread disturbances in health, social, pandemic. BMJ Global Health governance systems across the world. economic, environmental and governance systems in 2021;6:e006794. doi:10.1136/ ► Progress has been made in recent years to define many countries across the world. Resilience describes bmjgh-2021-006794 and assess health system resilience, but broader the capacities of natural and human systems to prevent, societal resilience to emerging infectious diseases react to and recover from shocks.
    [Show full text]
  • From Security to Risk: Reframing Global Health Threats
    From security to risk: reframing global health threats Article (Published Version) McInnes, Colin and Roemer-Mahler, Anne (2017) From security to risk: reframing global health threats. International Affairs, 93 (6). pp. 1313-1337. ISSN 0020-5850 This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/73652/ This document is made available in accordance with publisher policies and may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher’s version. Please see the URL above for details on accessing the published version. Copyright and reuse: Sussex Research Online is a digital repository of the research output of the University. Copyright and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable, the material made available in SRO has been checked for eligibility before being made available. Copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. http://sro.sussex.ac.uk From security to risk: reframing global health threats * COLIN MCINNES AND ANNE ROEMER-MAHLER In October 2014, at the height of the west African Ebola outbreak, the Director- General of the World Health Organization (WHO), Margaret Chan, commented: ‘In my long career in public health ..
    [Show full text]
  • COVID- , the UN, and Dispersed Global Health Security
    SPECIAL ISSUE: THE UNITED NATIONS AT SEVENTY-FIVE COVID-, the UN, and Dispersed Global Health Security Sophie Harman he picture is a chaotic one: the threat of the withdrawal of both U.S. funding and membership from the World Health Organization T (WHO); a delayed UN Security Council (UNSC) resolution on a major world crisis; and a large number of prominent world leaders ignoring scientific advice, downplaying a looming threat, and shifting away from multilateral coop- eration in responding to a crisis. By any measure, this reality has serious conse- quences for global health security and multilateralism within the UN system. Occurring at the height of a major pandemic, with immediate and long-term con- sequences for the lives and well-being of people around the world, these issues are downright dangerous. However, while COVID- exposes the fault lines in global health politics, it also demonstrates some of the positive gains made in global health security, including a subtle shift away from dependence on the UNSC and WHO. Institutional change and experience from previous global health emer- gencies have led to a more dispersed and inclusive form of global health security that is more equipped to respond to global political issues during a major pan- demic. The response to COVID- has shown this shift in four areas: () a sup- ported WHO; () a civil society and epistemic community of global health research and expertise; () obsolescence of the UNSC; and () timely inclusion of UN programs. WHO is at the center of global health security but does not define it. The orga- nization has been beleaguered by politics since the Cold War generated stasis and proxy wars over its membership, controversy surrounding eradication strategies, and obfuscation as to what “health for all” means and requires from member Ethics & International Affairs, , no.
    [Show full text]
  • Global Health in Disarray?: What Next? Biographies of Speakers Speakers
    GLOBAL HEALTH IN DISARRAY?: WHAT NEXT? BIOGRAPHIES OF SPEAKERS SPEAKERS ESPERANZA MARTINEZ Head of COVID-19 Crisis Management, International Committee of the Red Cross Esperanza Martinez is a global and humanitarian health expert currently leading the International Committee of the Red Cross (ICRC) Covid-19 crisis response. Prior to that, she was ICRC’s Head of Health and responsible for the provision of essential health care services to people affected by armed conflict and violence in more than 80 countries. She is a medical doctor and general surgeon, trained in Colombia, and specialised in International Public Health and Health Management in Australia. Her experience includes over ten years of fieldwork in conflict-affected countries as well as work with UN agencies, government bodies and the private sector. ALLAN MALECHE Executive Director, Kenya Legal & Ethical Issues Network on HIV & AIDS (KELIN) Allan Maleche is a dynamic leader, an advocate of the high court of Kenya and a human rights defender with over twelve years of experience in law, ethics, governance, policy, health and rights, including seven years managing rights-based programmes that protect affected, marginalised and vulnerable populations. He is currently serving as the Executive Director of Kenya Legal & Ethical Issues Network on HIV & AIDS (KELIN). He is a Co-chair of the UNAIDS Human Rights Reference group, and a former Board Member of the Developing Country NGO Delegation to the Global Fund Board, where he also served as Alternate Board Member. Allan is also a former member of the Global Fund’s Audit and Finance Committee, and the former Chair of the Implementers Group of the Global Fund Board.
    [Show full text]
  • Building a Multisystemic Understanding of Societal Resilience to the COVID-19 Pandemic
    Analysis BMJ Glob Health: first published as 10.1136/bmjgh-2021-006794 on 22 July 2021. Downloaded from Building a multisystemic understanding of societal resilience to the COVID-19 pandemic 1 1 2 3 Didier Wernli , Mia Clausin, Nino Antulov- Fantulin, John Berezowski, 4 5 6 7 Nikola Biller, Karl Blanchet , Lucas Böttcher, Claudine Burton- Jeangros, Gérard Escher,8 Antoine Flahault,9 Keiji Fukuda,10 Dirk Helbing,2 Philip D Jaffé,11 Peter Søgaard Jørgensen,12,13 Yuliya Kaspiarovich,1 Jaya Krishnakumar,14 15 16 1 1,17 Roderick John Lawrence, Kelley Lee , Anaïs Léger, Nicolas Levrat, 18 1 18 19,20 Romain Martischang, Chantal M Morel , Didier Pittet, Maxime Stauffer, Fabrizio Tediosi,21,22 Flore Vanackere,1 Jean- Dominique Vassalli,23,24 Gaélane Wolff,25 Oran Young26 To cite: Wernli D, Clausin M, ABSTRACT Summary box Antulov- Fantulin N, et al. The current global systemic crisis reveals how globalised Building a multisystemic societies are unprepared to face a pandemic. Beyond ► The COVID-19 pandemic has tested resilience in understanding of societal the dramatic loss of human life, the COVID-19 pandemic resilience to the COVID-19 health but also social, economic, environmental and has triggered widespread disturbances in health, social, pandemic. BMJ Global Health governance systems across the world. economic, environmental and governance systems in 2021;6:e006794. doi:10.1136/ ► Progress has been made in recent years to define many countries across the world. Resilience describes bmjgh-2021-006794 and assess health system resilience, but broader the capacities of natural and human systems to prevent, societal resilience to emerging infectious diseases react to and recover from shocks.
    [Show full text]
  • A74/9 Add.1 Provisional Agenda Item 17.3 5 May 2021
    SEVENTY-FOURTH WORLD HEALTH ASSEMBLY A74/9 Add.1 Provisional agenda item 17.3 5 May 2021 WHO’s work in health emergencies Strengthening preparedness for health emergencies: implementation of the International Health Regulations (2005) The Director-General has the honour to transmit to the Seventy-fourth World Health Assembly the report of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 Response (see Annex). A74/9 Add.1 ANNEX Report of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 response Final Draft, 30 April 2021 Page Contents Acknowledgements ................................................................................................................................................ 4 Preface .................................................................................................................................................................... 6 Acronyms and abbreviations .................................................................................................................................. 8 Executive summary ................................................................................................................................................ 9 1. Introduction and background ............................................................................................................................ 18 1.1 A brief introduction to the IHR .................................................................................................................
    [Show full text]